Valley Ventures III

Valley Ventures III is a venture capital fund managed by Valley Ventures, a Phoenix-based firm specializing in life science and technology investments. Established in 2002 with approximately $41.2 million in capital, the fund has focused on early and late-stage companies in the southwestern United States, particularly in the fields of biotechnology, medical devices, and diagnostics. Key investments include HTG Molecular Diagnostics, Vital Therapies, and Regenesis Biomedical. The fund is led by John M. Holliman III, a prominent venture capitalist who also serves as the Executive Chairman of Capstone Therapeutics. Valley Ventures III has played a significant role in the Arizona biotech ecosystem, supporting the development of novel therapeutics and diagnostic platforms.